Influence of Clinical Trial Participation on Subsequent Antithrombin Use

BACKGROUND: Results from the Superior Yield of the New Strategy of Enoxaparin, Revascularization, and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial showed that the low‐molecular‐weight heparin (LMWH) enoxaparin was non‐inferior compared with unfractionated heparin (UFH) in patients with non‐ST‐el...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cardiol
Main Authors: Shah, Bimal R., Peterson, Eric D., Chen, Anita Y., Mahaffey, Kenneth W., DeLong, Elizabeth R., Magnus Ohman, E., Pollack, Charles V., Brian Gibler, W., Roe, Matthew T.
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Periodicals, Inc. 2010
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6653075/
https://ncbi.nlm.nih.gov/pubmed/20127904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20581
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados